NYSE's Roadmap to Wall Street – Managing communications and investor engagement for a US listing, by a CFO who has done it many times
The cautious optimism that we have been talking about all year is still with us. Companies may not be racing to the IPO market yet, but many are considering it and the US remains the most attractive prospect. Several European companies attended the NYSE’s “Roadmap to Wall Street” event in London last month, at which the New York Stock Exchange, and advisers from the legal, financial, communications and investor relations worlds, led sessions to share their experience on how to prepare for a US listing.
LinkQ&A with Mandeep Sehmi, Head of Business Development at Scancell
The American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago from 31 May to 4 June 2024, is one of the most prominent and highly regarded events in the oncology calendar. This year’s event will contain over 200 presentations by leading scientists and companies discussing the latest progress in cancer research and treatment. We asked Dr Mandeep Sehmi, Head of Business Development at Scancell, one of the companies presenting, what excites her about this year’s event.
LinkClinical Trials Day
Clinical Trials Day (May 20th) is an opportunity to celebrate the central role that clinical trials play in healthcare and to acknowledge the hard work of researchers, healthcare professionals and volunteers.
LinkLazard T500 Conference
Lazard’s T500 conference, held in London from May 7-9, has become a key talking shop for Europe’s venture and scale-up ecosystem, bringing together venture-backed companies from healthcare, tech and fintech to meet investors and advisers. On the first sunny day after the wettest spring in London for years, entrepreneurs and financiers stood blinking on the sun-drenched terrace just around the corner from the Savoy Hotel overlooking the Thames, clutching coffee and the mood was palpably upbeat.
LinkThe inside track on AACR, from Dr Christina Coughlin, Head of R&D, Avacta
Dr Christina Coughlin, Head of R&D at UK targeted oncology developer Avacta, an experienced biotechnology executive and oncologist, is attending the American Association of Cancer Research Annual Meeting, in San Diego. She talked to us about the congress, why it matters to people in cancer research and development, and what the buzz is this year.
LinkRising above the noise, by Suki Virji, PhD, Senior Associate Partner
ICR Consilium regularly attends BioEquity and this year is proud to be a supporting company of the meeting, which is hosted by BioCentury Inc. and EBD Group.
LinkRare Disease Day 2024
Every day we are proud to be working with innovators leading the way in developing therapies to treat rare diseases. 29 February, the rarest day of the calendar, is Rare Disease Day and members of our team are highlighting some of the rare diseases that our clients are focused on.
LinkAMD Awareness Month with Dr Daniel C. Chung
Age-related macular degeneration (AMD) is a disease that can result in severe loss of central vision. February is AMD Awareness Month, so we asked Dr Daniel C. Chung, Chief Medical Officer at SparingVision to explain what the disease is, who is most at risk and its impact on patients.
LinkNot ‘digital healthcare’ – just ‘healthcare’
Senior Associate Partner Chris Welsh and Associate Partner Kris Lam recently attended the Basel Healthtech Conference hosted by MTIP and Stifel, where conversations circled around topics such as the intricacies of data management, enhancing the patient experience in clinical trials and leveraging technology to optimize drug discovery and application.
LinkInternational Day of Women and Girls in Science 2024
At ICR Consilium, we are celebrating all women and girls in science and are proud to be working alongside remarkable women in the industry every day. We asked two female CEOs on what International Day of Women and Girls in Science means to them.
Link